Advertisement
Advertisement
U.S. markets close in 58 minutes
Advertisement
Advertisement
Advertisement
Advertisement

KemPharm, Inc. (KMPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.7700-0.0500 (-1.04%)
As of 03:02PM EST. Market open.
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
10,721
28,650
13,288
12,839
0
Cost of Revenue
259
2,059
1,305
2,945
-
Gross Profit
10,462
26,591
11,983
9,894
-
Operating Expense
28,893
18,862
16,764
30,231
54,267
Operating Income
-18,431
7,729
-4,781
-20,337
-54,267
Net Non Operating Interest Income Expense
-210
-128
-7,001
-6,205
-6,667
Other Income Expense
-17,302
-16,122
-1,012
1,998
4,342
Pretax Income
-35,943
-8,521
-12,794
-24,544
-56,592
Tax Provision
-718
34
-34
-22
-126
Net Income Common Stockholders
-35,225
-62,897
-12,760
-24,522
-56,466
Diluted NI Available to Com Stockholders
-35,225
-62,897
-12,760
-24,522
-56,466
Basic EPS
-
-2.11
-3.21
-13.28
-50.40
Diluted EPS
-
-2.11
-3.21
-13.28
-50.40
Basic Average Shares
-
29,766
3,981
1,853
1,121
Diluted Average Shares
-
29,766
3,981
1,853
1,121
Total Operating Income as Reported
-36,094
7,729
-5,609
-20,337
-55,903
Total Expenses
29,152
20,921
18,069
33,176
54,267
Net Income from Continuing & Discontinued Operation
-35,225
-8,555
-12,760
-24,522
-56,466
Normalized Income
-18,269
3,214
-11,751
-26,518
-60,798
Interest Income
-
248
89
309
420
Interest Expense
322
376
7,090
6,514
7,087
Net Interest Income
-210
-128
-7,001
-6,205
-6,667
EBIT
-35,621
-8,145
-5,704
-18,030
-49,505
EBITDA
-34,913
-
-
-
-
Reconciled Cost of Revenue
259
2,059
1,305
2,945
-
Reconciled Depreciation
708
257
273
304
324
Net Income from Continuing Operation Net Minority Interest
-35,225
-8,555
-12,760
-24,522
-56,466
Total Unusual Items Excluding Goodwill
-17,302
-16,122
-1,012
1,998
4,342
Total Unusual Items
-17,302
-16,122
-1,012
1,998
4,342
Normalized EBITDA
-17,611
8,234
-4,419
-19,724
-53,523
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-345.626
-4,353
-2.6312
1.7909
9.6673
Advertisement
Advertisement